Evidence map›Paper›PMID 32377964›Full record

ArticleArchives of osteoporosis2020

A surrogate FRAX model for the Kyrgyz Republic.

O Lesnyak, A Zakroyeva, O Lobanchenko, H Johansson, E Liu, M Lorentzon, N C Harvey, E McCloskey, J A Kanis

Abstract read
In one paragraph

Article in Archives of osteoporosis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A surrogate FRAX model for Nepal.Archives of osteoporosis · 2024
    Article
  2. Article
  3. A surrogate FRAX model for Pakistan.Archives of osteoporosis · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

O LesnyakMechnikov North West State Medical University, St. Petersburg, Russia.
A ZakroyevaUral State Medical University, Yekaterinburg, Russia.
O LobanchenkoI.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyz Republic.
H JohanssonMary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
E LiuMary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
M LorentzonMary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
N C HarveyMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
E McCloskeyCentre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
J A KanisMary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia. w.j.pontefract@sheffield.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hip fracture rates from Kazakhstan were used to create a surrogate FRAX® model for the Kyrgyz Republic.

introductionThe International Society for Clinical Densitometry and International Osteoporosis Foundation recommend utilizing a surrogate FRAX model, based on the country-specific risk of death, and fracture data based on a country where fracture rates are considered to be representative of the index country.

objectiveThis paper describes a surrogate FRAX model for the Kyrgyz Republic.

methodsThe FRAX model used the incidence of hip fracture from the neighbouring country of Kazakhstan and the death risk for the Kyrgyz Republic.

resultsCompared with the model for Kazakhstan, the surrogate model gave somewhat higher 10-year fracture probabilities for men between 60 and 80 years of age and lower probabilities for men above the age of 80. For women the probabilities were similar up to the age of 75-80 years and then lower. There were very close correlations in fracture probabilities between the surrogate and authentic models (1.00) so that the use of the Kyrgyz model had little impact on the rank order of risk. It was estimated that 2752 hip fractures arose in 2015 in individuals over the age of 50 years in the Kyrgyz Republic, with a predicted increase by 207% to 8435 in 2050.

conclusionThe surrogate FRAX model for the Kyrgyz Republic provides the opportunity to determine fracture probability among the Kyrgyz population and help guide decisions about treatment.

Indexed as

Hip FracturesAgedAged, 80 and overBone DensityFemaleHumansKazakhstanKyrgyzstanMaleMiddle AgedOsteoporotic FracturesRisk AssessmentRisk FactorsEpidemiologyFracture probabilityFRAXHip fractureKazakhstanKyrgyz RepublicSurrogate

Identifiers

PMID32377964
PMCPMC7203583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.